Midgard Science

CuriRx, Inc.

Wilmington, MA, United States curirx.com From their website, Nov 2026

Work here? Claim this listing

About

CuriRx, Inc. is a pharmaceutical CDMO in Wilmington, Massachusetts. It provides formulation, bioprocessing, analytical, quality testing, and CMC support services for biopharmaceuticals, biologics, small molecules, and gene therapy products.

Services

  • Formulation Development

    Develops pharmaceutical formulations for injectables and other dosage forms, including liquid, lyophilized, nanoparticle, microemulsion, nanoemulsion, and complexation formats.

  • Formulation Studies

    Performs preformulation studies such as Stability Fingerprinting® for biotherapeutics and Solubility Fingerprinting® for small molecules.

  • Lyophilization

    Supports lyophilized product development for stability, transport, storage, and clinical progression.

  • Nanotechnology

    Develops lipid nanoparticle-based delivery systems for mRNA, DNA, ADCs, antibodies, small molecules, and other modalities.

  • Advanced Bioprocessing

    Provides end-to-end bioprocessing development spanning cell line and strain development, upstream process development, and downstream process development.

    Protein production

  • Cell Line and Strain Development

    Develops production strains and expression systems using GS, DHFR, CHO, E. coli, yeast, and transient transfection approaches.

  • Upstream Process Development

    Develops and scales cell culture processes from vector construction through harvest, including media, feed, and bioreactor condition optimization.

    Protein production

  • Downstream Process Development

    Develops purification and viral clearance workflows using chromatography, filtration, and related purification steps.

    Protein production

10 more services
  • Analytical Services
  • CuriLytics® CMC Analytical Support
  • High Resolution Mass Spectrometry
  • CMC Support Services
  • Analytical Testing Services
  • Quality Testing
  • Prefilled Syringes
  • CMC Analytical Support
  • Qualification and Validation
  • Stability Studies

Capabilities

Assays and studies
  • Process development
  • Antibodies
  • Lyophilization
  • Peptides
  • Small molecules
  • Stability studies
22 more
  • Analytical development
  • ADCs
  • Solubility Fingerprinting®
  • Stability Fingerprinting®
  • Peptide mapping
  • Protein identification
  • Antibody/protein characterization
  • Protein post-translational modification analysis
  • Disulfide bond mapping
  • Glycan profiling
  • Host cell protein analysis
  • Release testing
  • Stability testing
  • Method development
  • Method transfer
  • Method validation
  • Method qualification
  • Post-translational modification analysis
  • Protein aggregation analysis
  • Protein quantitation
  • Product release testing
  • API release testing
Scale and capacity
  • 1L to 10L bioreactors
  • 250 mL to 40 L scale single-use bioreactors
  • 9x3L bioreactors
  • 8x1-2L parallel bioreactors
Therapeutic areas
  • Biopharmaceuticals
  • Biologics
  • Gene therapy

Instruments and platforms

  • LyoStar II-FTS Lyophilizer
  • FACS
  • Cell imager
  • CEDEX
  • NOVA Bioprofile
  • NOVA CDV
8 more
  • AKTA pure
  • AKTA Prime Plus
  • AKTA Pilot
  • High resolution mass spectrometry
  • LC/MS
  • RP LC/MS/MS
  • SEC-HPLC
  • SEC-HRMS

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Oligonucleotide
4 more
  • mRNA
  • Viral vector
  • Vaccine
  • LNP / formulation
Species and models
  • CHO
  • ExpiCHO
  • CHOK1
  • CHOZN
  • E. coli
  • Yeast
5 more
  • Saccharomyces cerevisiae
  • Pichia pastoris
  • Insect
  • Mammalian
  • Bacterial

Industries served

  • Pharmaceuticals
  • Biotechnology

Details

Type
CRDMO
Quality
USP 1055 · ICH Q6B (CMC support and analytical characterization) · ICH guidelines (stability studies) · NDA · BLA · ANDA · 505(b)(2)
Based in
Wilmington, MA, United States
Phone
978-658-2962

Similar labs